back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-27 16:19 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,512,069 | |
| Filed 2024-06-10 17:01 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$131,666
+346,490 vol $0.38 each |
5,596,490 | |
| Filed 2024-06-10 17:00 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-450,000 vol |
1,212,069 | |
| Filed 2023-12-22 11:00 Tx date 2023-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
0 | |
| Filed 2023-10-02 21:33 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,662,069 | |
| Filed 2022-06-28 16:10 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,239
+238,786 vol $1.45 each |
1,162,069 | |
| Filed 2021-09-24 17:36 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$278,348
+88,646 vol $3.14 each |
923,283 | |
| Filed 2020-11-05 09:18 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$176,995
+34,637 vol $5.11 each |
834,637 | |
| Filed 2019-11-11 16:24 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$260,000
+200,000 vol $1.30 each |
800,000 | |
| Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+200,000 vol $1.00 each |
600,000 | |
| Filed 2018-12-27 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$120,000
+100,000 vol $1.20 each |
100,000 | |
| Filed 2018-12-22 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,000
+200,000 vol $1.00 each |
5,250,000 | |
| Filed 2017-09-26 Tx date 2017-09-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$301,499
+150,000 vol $2.01 each |
400,000 | |
| Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,050,000 | ||
| Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aries Biologics (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,500,000 |